DAVIDE CAMPARI-MILANO NV (CPR.MI) Stock Fundamental Analysis

BIT:CPR • NL0015435975

6.686 EUR
+0.18 (+2.7%)
Last: Feb 20, 2026, 05:36 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

Taking everything into account, CPR scores 4 out of 10 in our fundamental rating. CPR was compared to 30 industry peers in the Beverages industry. CPR has an average financial health and profitability rating. CPR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year CPR was profitable.
  • In the past year CPR had a positive cash flow from operations.
  • Each year in the past 5 years CPR has been profitable.
  • CPR had a positive operating cash flow in each of the past 5 years.
CPR.MI Yearly Net Income VS EBIT VS OCF VS FCFCPR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

  • CPR has a Return On Assets of 2.51%. This is in the lower half of the industry: CPR underperforms 66.67% of its industry peers.
  • The Return On Equity of CPR (5.44%) is worse than 70.00% of its industry peers.
  • With a Return On Invested Capital value of 7.03%, CPR perfoms like the industry average, outperforming 56.67% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CPR is in line with the industry average of 7.64%.
Industry RankSector Rank
ROA 2.51%
ROE 5.44%
ROIC 7.03%
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
CPR.MI Yearly ROA, ROE, ROICCPR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 6.57%, CPR is doing worse than 60.00% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CPR has declined.
  • CPR's Operating Margin of 21.32% is fine compared to the rest of the industry. CPR outperforms 63.33% of its industry peers.
  • In the last couple of years the Operating Margin of CPR has remained more or less at the same level.
  • CPR's Gross Margin of 57.55% is fine compared to the rest of the industry. CPR outperforms 73.33% of its industry peers.
  • CPR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.32%
PM (TTM) 6.57%
GM 57.55%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
CPR.MI Yearly Profit, Operating, Gross MarginsCPR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CPR is creating some value.
  • Compared to 1 year ago, CPR has more shares outstanding
  • Compared to 5 years ago, CPR has more shares outstanding
  • CPR has about the same debt/assets ratio as last year.
CPR.MI Yearly Shares OutstandingCPR.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
CPR.MI Yearly Total Debt VS Total AssetsCPR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • An Altman-Z score of 2.72 indicates that CPR is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • CPR has a Altman-Z score of 2.72. This is in the better half of the industry: CPR outperforms 76.67% of its industry peers.
  • The Debt to FCF ratio of CPR is 8.49, which is on the high side as it means it would take CPR, 8.49 years of fcf income to pay off all of its debts.
  • CPR has a Debt to FCF ratio of 8.49. This is comparable to the rest of the industry: CPR outperforms 43.33% of its industry peers.
  • CPR has a Debt/Equity ratio of 0.64. This is a neutral value indicating CPR is somewhat dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.64, CPR is doing good in the industry, outperforming 70.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 8.49
Altman-Z 2.72
ROIC/WACC1.02
WACC6.89%
CPR.MI Yearly LT Debt VS Equity VS FCFCPR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 2.32 indicates that CPR has no problem at all paying its short term obligations.
  • CPR has a better Current ratio (2.32) than 86.67% of its industry peers.
  • A Quick Ratio of 0.91 indicates that CPR may have some problems paying its short term obligations.
  • CPR has a better Quick ratio (0.91) than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 0.91
CPR.MI Yearly Current Assets VS Current LiabilitesCPR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • CPR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -40.50%.
  • CPR shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.12% yearly.
  • The Revenue has been growing slightly by 5.18% in the past year.
  • CPR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.75% yearly.
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-8.36%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%0.3%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.84% on average over the next years. This is quite good.
  • CPR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.85% yearly.
EPS Next Y2.19%
EPS Next 2Y4.77%
EPS Next 3Y7.34%
EPS Next 5Y10.84%
Revenue Next Year1.47%
Revenue Next 2Y1.82%
Revenue Next 3Y2.95%
Revenue Next 5Y3.85%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CPR.MI Yearly Revenue VS EstimatesCPR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B
CPR.MI Yearly EPS VS EstimatesCPR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 39.33, which means the current valuation is very expensive for CPR.
  • 80.00% of the companies in the same industry are cheaper than CPR, based on the Price/Earnings ratio.
  • CPR's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.99.
  • Based on the Price/Forward Earnings ratio of 20.52, the valuation of CPR can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, CPR is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
  • CPR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.02.
Industry RankSector Rank
PE 39.33
Fwd PE 20.52
CPR.MI Price Earnings VS Forward Price EarningsCPR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • CPR's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CPR is more expensive than 60.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CPR is valued a bit more expensive than 63.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 25.65
EV/EBITDA 13.1
CPR.MI Per share dataCPR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CPR does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)17.98
PEG (5Y)N/A
EPS Next 2Y4.77%
EPS Next 3Y7.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. Dividend

5.1 Amount

  • CPR has a yearly dividend return of 0.96%, which is pretty low.
  • CPR's Dividend Yield is slightly below the industry average, which is at 2.30.
  • With a Dividend Yield of 0.96, CPR pays less dividend than the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 0.96%

5.2 History

  • The dividend of CPR decreases each year by -2.80%.
Dividend Growth(5Y)-2.8%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 38.69% of the earnings are spent on dividend by CPR. This is a low number and sustainable payout ratio.
DP38.69%
EPS Next 2Y4.77%
EPS Next 3Y7.34%
CPR.MI Yearly Income VS Free CF VS DividendCPR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
CPR.MI Dividend Payout.CPR.MI Dividend Payout, showing the Payout Ratio.CPR.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

DAVIDE CAMPARI-MILANO NV

BIT:CPR (2/20/2026, 5:36:15 PM)

6.686

+0.18 (+2.7%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)10-29
Earnings (Next)03-04
Inst Owners23.2%
Inst Owner ChangeN/A
Ins Owners50.8%
Ins Owner ChangeN/A
Market Cap8.23B
Revenue(TTM)3.07B
Net Income(TTM)201.60M
Analysts72.59
Price Target7 (4.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.96%
Yearly Dividend0.04
Dividend Growth(5Y)-2.8%
DP38.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.69%
PT rev (3m)1.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.37%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE 39.33
Fwd PE 20.52
P/S 2.68
P/FCF 25.65
P/OCF 12.62
P/B 2.22
P/tB 67.81
EV/EBITDA 13.1
EPS(TTM)0.17
EY2.54%
EPS(NY)0.33
Fwd EY4.87%
FCF(TTM)0.26
FCFY3.9%
OCF(TTM)0.53
OCFY7.92%
SpS2.49
BVpS3.01
TBVpS0.1
PEG (NY)17.98
PEG (5Y)N/A
Graham Number3.39
Profitability
Industry RankSector Rank
ROA 2.51%
ROE 5.44%
ROCE 9.58%
ROIC 7.03%
ROICexc 7.57%
ROICexgc 17.42%
OM 21.32%
PM (TTM) 6.57%
GM 57.55%
FCFM 10.45%
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
ROICexc(3y)8.52%
ROICexc(5y)8.34%
ROICexgc(3y)23.37%
ROICexgc(5y)25.9%
ROCE(3y)10.45%
ROCE(5y)9.91%
ROICexgc growth 3Y-20.45%
ROICexgc growth 5Y-21.73%
ROICexc growth 3Y-7.67%
ROICexc growth 5Y-5.91%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 8.49
Debt/EBITDA 2.97
Cap/Depr 230.39%
Cap/Sales 10.79%
Interest Coverage 6.41
Cash Conversion 81.69%
Profit Quality 159.18%
Current Ratio 2.32
Quick Ratio 0.91
Altman-Z 2.72
F-Score6
WACC6.89%
ROIC/WACC1.02
Cap/Depr(3y)346.34%
Cap/Depr(5y)266.11%
Cap/Sales(3y)12.99%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-8.36%
EPS Next Y2.19%
EPS Next 2Y4.77%
EPS Next 3Y7.34%
EPS Next 5Y10.84%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%0.3%
Revenue Next Year1.47%
Revenue Next 2Y1.82%
Revenue Next 3Y2.95%
Revenue Next 5Y3.85%
EBIT growth 1Y6.42%
EBIT growth 3Y15.63%
EBIT growth 5Y10.27%
EBIT Next Year26.24%
EBIT Next 3Y12.26%
EBIT Next 5Y10.04%
FCF growth 1Y290.11%
FCF growth 3Y-14.61%
FCF growth 5Y-4.94%
OCF growth 1Y205.34%
OCF growth 3Y11.5%
OCF growth 5Y13.06%

DAVIDE CAMPARI-MILANO NV / CPR.MI FAQ

Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?

ChartMill assigns a fundamental rating of 4 / 10 to CPR.MI.


What is the valuation status for CPR stock?

ChartMill assigns a valuation rating of 1 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.


What is the profitability of CPR stock?

DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 4 / 10.


Can you provide the financial health for CPR stock?

The financial health rating of DAVIDE CAMPARI-MILANO NV (CPR.MI) is 5 / 10.


Can you provide the expected EPS growth for CPR stock?

The Earnings per Share (EPS) of DAVIDE CAMPARI-MILANO NV (CPR.MI) is expected to grow by 2.19% in the next year.